Niacin, a vitamin B3 form improves NAD+ levels and improves muscle strength and performance in patients with the progressive muscle disease, mitochondrial myopathy, according to an international team of scientists.
Researchers linking the effects of vitamin B3 deficiency to incidences of psychosis could hold the key to solving ‘medical mysteries’ associated with the condition, and may provide hopes for those in developing countries.
The BfR – Germany’s Federal Institute for Risk Assessment – has called on consumers to refrain from taking nicotinic acid in excessive dosages as it is ‘damaging’ to health even if it is not widely used in Europe, according to an industry expert.
Swiss biotech company Lonza has announced that it is on track to
meet the earnings expectations for full year 2006, with high raw
material and energy costs in the organic fine and performance
chemicals division successfully passed...
Swiss chemicals group Lonza has announced a strategic investment of
$200m in its operations in China, with the investment boosting all
the business including its rapidly expanding nutrition business
Swiss fine chemicals group Lonza said yesterday that it saw strong
demand for its nutrition products during the first half but high
raw material and energy costs continued to erode margins, writes
Niacin, the B vitamin which is known to raise blood glucose levels
when consumed in large quantities - making it inappropriate for use
as a diabetes treatment - could in fact be effective in treating
the disease, provided the dosage...
Researchers from Canada have discovered that many dietary
supplement users are unaware of the tolerable upper limits and as
such could be putting themselves at risk instead of doing
themselves some good.